ClinicalTrials.gg
RecruitingNCT07003932OA-AID TKRUpdated May 19, 2026

Remote Monitoring After Knee Replacement Surgery

An interventional study of Remote monitoring and Usual Care in Knee Arthroplasty, Total and Knee Replacement Arthroplasty, sponsored by Diakonhjemmet Hospital. Recruiting at 1 site in Norway. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Diakonhjemmet Hospital · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the effect, cost-effectiveness, safety and satisfaction with replacing standardized, pre-scheduled face-to-face visits with remote monitoring and video consultations or face-to-face consultations only when needed after knee replacement surgery due to knee osteoarthritis.

The primary outcome is the probability of being a OMERACT-OARSI responder at 6 months post-surgery. This is a composite index where participants are classified as a responder or non-responder based on improvement in pain, function and/or disease activity. Health-related quality of life and healthcare costs will be used to determine cost-effectiveness. Patient-reported adverse events and statisfaction will be used to determine safety and satisfaction.

Patients will be recruited from Diakonhjemmet Hospital. Patients undergoing knee replacement surgery will be randomly allocated to a control group who are summoned for a face-to-face consultation at Diakonhjemmet Hospital at 2 and 12 months, or a remote monitoring group who will not be scheduled for hospital visits but will answer patient-reported outcomes throught a web-application at 1, 2, 3, 6 and 12 months post-surgery and only be scheduled for hospital visits when needed.

An additional study with follow-up after 5 and 10 years will be conducted.

Read the detailed description

Participants are eligible for inclusion in the study if the following criteria apply:

  • men and women, 50 years of age or older
  • referred to total or unicondylar (medial) knee replacement surgery due to knee osteoarthritis

Participants are excluded from the study of any of the following criteria apply:

  • revision of previous knee replacement surgery
  • serious comorbidities (such as severe malignancues, severe diabetes mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease, severe respiratory disease)
  • congnitive dysfunction
  • knee replacement surgery due to trauma or inflammatory joint disease (such as psoriatic arthritis or rheumatoid arthritis)
  • unable to understand Norwegian
  • Cannot answer questionnaires digitally (lack BankID, do not possess a smartphone
  • deemed inappropriate for remote monitoring by orthopedic surgeon

Patients included in both treatment arms will receive medical treatment according to current treatment recommendations as applied by the treating orthopedic surgeon after total knee replacement. All partients are recommended to seek physiotherapy treatment in primary care after surgery

Patients randomly allocated to the control group will be summoned for a hospital visit with a physiotherapist at 2 and 12 months. The physiotherapist will conduct assessment in line with regular clinical practice. If the patient is experiencing lack of improvement or adverse events, an orthopedic surgeon may be consulted. The patients will also answer patient-reported outcomes at 8 weeks and 6- and 12 months post-surgery, however, these answers will not be monitored.

Patients randomly allocated to the remote monitoring group will answer patient-reported outcome at 1, 2, 3, 6 and 12 months. They will be provided with a brief introduction from the study personnel on how to answer questions remotely through the Youwell platform. Patients will get an SMS notification on their mobile phone with a link to the questionnaire. They will have to log in with BankID to access the questionnaire. A physiotherapist will monitor the answers and will contact the patient if an unexpected deterioration or adverse events are detected.

Data will be collected through Nettskjema or the Youwell/Dignio software program and will be stored in Services for Sensitive Data (TSD) and a a secure server at Diakonhjemmet Hospital.

The following data will be recorded through self-report in the baseline questionnaire:

  • Demography: mobile number, education, work status, living arrangement, socioeconomic status, social support, expectations about treatment, fear of movement, catastrophizing, self-efficacy
  • Disease variables: KOOS, other joints with osteoarthritis, duration of complaint, previous treatment, fatigue, disease activity, pain, function, pain medication, osteoarthritis quality indicators, knee flexion/extension, use of walking aids
  • Lifestyle variables: physical activity, motivation for exercise, motivation for surgery
  • Health competency, digital self-efficacy
  • Patient satisfaction
  • Health-related quality of life The following information will be collected from medical records
  • Demographic variables: Age, gender, height, weight, comorbidity, referred knee, smoking,
  • General medical history: description of radiographs, type of scheduled arthroplasty, joint status prior to surgery

Patients allocated to the remote monitoring group will receive an SMS with link to questionnaires in the Youwell/Dignio platform at 1, 2, 3, 6 and 12 months. The following data will be collected for the remote monitoring group:

  • Global rating of change
  • Pain/Pain medication
  • Fear of movement
  • Expectations about treatment
  • Disease activity
  • Signs inflammation/swelling
  • Function/activity
  • Knee flexion/extension
  • Use of walking aids
  • Exercise
  • Contact with physiotherapist/ rehabilitation stay
  • Adverse events
  • Patient satisfaction with care

A highly experienced physiotherapist will review the answers and based on these make a clinical judgement whether there is a need to call the patient or summon the patient for a physical examination, or if the patient seems to manage well at home.

Patients in the control group will also answer the remote monitoring questionnaire at 2 months, however, their answers will not be monitored (just for research purposes).

At follow-up, the following variables will be collected:

  • Global rating of change
  • Disease variables: KOOS, fatigue, disease activity, pain, function, pain medication,
  • Fear of movement
  • Self-efficacy
  • Knee flexion/extension
  • Lifestyle variables: physical activity,
  • Patient satisfaction with care
  • Health-related quality of life
  • Health care costs: hospital stay, rehabilitation stay, travel distance to hospital, transportation, health care use
  • Adverse events
02

Conditions studied

  • Knee Arthroplasty, Total
  • Knee Replacement Arthroplasty

Keywords

  • knee arthroplasty
  • remote follow-up
  • non-inferiority
03

In context

Lead sponsor

Diakonhjemmet Hospital is the lead sponsor of 62 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women, 50 years of age or older
  • Referred to total or unicondylar knee replacement surgery due to knee osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • Revision of previous knee replacement surgery
  • Serious comorbidities (such as severe , severe diabetes mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease, severe respiratory disease)
  • Congitive dysfunction
  • Knee replacement surgery due to trauma or inflammatory joint disease (such as psoriatic arthritis or rheumatoid arthritis)
  • Unable to understand Norwegian
  • Low digital competency/ cannot answer questionnaires digitally (lack BankID, do not possess a smartphone)
  • Deemed inappropriate for remote monitoring by orthopedic surgeon
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    Control group

    Patients randomly allocated to standard follow-up will be summoned for a hospital visit with a physiotherapist at 8 weeks and 12 months post-surgery. The physiotherapist will conduct an assessment in line with regular clinical practice. If the patient is experiencing lack of improvement or adverse events, an orthopedic surgeon may be consulted. The patients will also answer patient-reported outcomes at 8 weeks and 6- and 12 months post-surgery, however, these answers will not be monitored.

    Other: Usual Care

  • Experimental
    Remote monitoring

    Patients randomly allocated to the remote monitoring group will answer patient-reported outcome at 1, 2, 3, 6 and 12 months. They will be provided with a brief introduction from the study personnel on how to answer questions remotely through the Youwell/Dignio platform. Patients will get an SMS notification on their mobile phone with a link to the questionnaire. They will have to log in with BankID to access the questionnaire. A physiotherapist will monitor the answers and will contact the patient if an unexpected deterioration or adverse events are detected.

    Other: Remote monitoring

Interventions

  • OtherRemote monitoring

    The remote monitoring group will be more closely followed than the control group in order to detect any deterioration over time. This group will not be scheduled for a face-to-face consultation unless it is deemed necessary by a physiotherapist or if the patient contacts the hospital themselves.

  • OtherUsual Care

    The control group will follow usual care with face-to-face consultation with a physiotherapist at 2 and 12 months. They will also anwer questionnaires at 2, 6 and 12 months, but these will not be monitored.

06

What researchers measure

Primary outcomes

  1. OMERACT-OARSI responder criteria

    The OMERACT-OARSI responder criteria is a composite index where participants are classifies as responders or non-responders (binary outcome) based on the following criteria: High improvement on pain or function * ≥50% improvement + absolute change of ≥2 points in pain, OR * ≥50% improvement + absolute change of ≥2 point on KOOS) OR Improvement in at least two of the three following * ≥20% improvement + absolute change of ≥1 point in pain * ≥20% improvement + absolute change of ≥1 point in function * ≥20% improvement + absolute change of ≥1 point in disease activity

    Time frame: Baseline, 6 months

Secondary outcomes

  1. OMERACT-OARSI responder criteria

    The OMERACT-OARSI responder criteria is a composite index where participants are classifies as responders or non-responders (binary outcome) based on the following criteria: High improvement on pain or function • ≥50% improvement + absolute change of ≥2 points in pain, OR • ≥50% improvement + absolute change of ≥2 point on KOOS) OR Improvement in at least two of the three following • ≥20% improvement + absolute change of ≥1 point in pain • ≥20% improvement + absolute change of ≥1 point in function • ≥20% improvement + absolute change of ≥1 point in disease activity

    Time frame: Baseline, 12 months

  2. Healthcare costs

    Direct (consultations in primary or specialist healthcare) and indirect costs (sick leave, medication, travel costs) collected from national registers (NAV, KUHR, NPR) or self-report. Summed up to cost per patient (euro).

    Time frame: Baseline, 6 and 12 months

  3. Health-related quality of life (EQ5D-5L)

    5 dimensions rated on a 5-point Likert scale, calculated utility score between 0 and 1 (best health)

    Time frame: Baseline, 6 months, 12 months

  4. Safety measures

    Any adverse events during the follow-up period. Any contact with hospital, emergency unit and general practitioned due to acute worsening. 1 and 3 months only for the remote monitoring group

    Time frame: 1 month, 2 months, 3 months, 6 months, 12 months

  5. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Assessment of three dimentions of the KOOS (pain, activity in daily living and health-related quality of life) summed up to 0-100 scales where 100 is best score.

    Time frame: Baseline, 6 months, 12 months

  6. Change in pain

    Measured on numeric rating scales (0-10) with higher score indicating more pain

    Time frame: Baseline, 2 months, 6 months, 12 months

  7. Change in disease activity

    Measured on a numeric rating scale (0-10) with 10 indicating worst disease activity.

    Time frame: Baseline, 2 months, 6 months, 12 months

  8. Satisfaction with care

    Measured on a numeric rating scale (0-10) with higher score indicating higher satisfaction with care.

    Time frame: 2 months, 6 months, 12 months

  9. Satisfaction with total knee replacement surgery

    Assessed using 4 primary questions, each rated on a 5-point Likert scale (from "very satisfied" to "very dissatisfied"), and a question about change in health-related quality of life rated on a 6-point scale (from "more improvement than I ever dreamed about" to "the quality of my life is worse")

    Time frame: 2 months, 6 months, 12 months

  10. Change in range of motion

    Knee flexion and extension is self-reported based on pictures of different degrees of range of motion. Measurement at 1 and 3 months only for the remote monitoring group.

    Time frame: Baseline, 1, 2, 3, 6, 12 months

  11. Number of extra visits

    Number of extra visits in both groups

    Time frame: Baseline to 12 months

Other outcomes

  1. Fatigue

    Measured on a numeric rating scale (0-10) with 10 indicating most fatigue

    Time frame: Baseline, 2 months, 6 months, 12 months

  2. Change in problems related to daily activity

    Measured on a numeric rating scale (0-10) with 10 indicating more problems (question no.6 in the WPAI questionnaire)

    Time frame: Baseline, 2 months, 6 months, 12 months

  3. Pain self-efficacy Questionnaire (PSEQ-2)

    Two questions on pain self-efficacy measured on a 6-point scale (not at all confident to completely confident)

    Time frame: Baseline, 2 months, 6 months, 12 months

  4. OsteoArthritis Quality Indicator questionnaire

    17 item quality indicator questionnaire with yes, no, don't know/not relevant response categories. Summarized to a pass rate (number of yes divided by number of yes+number of no responses)

    Time frame: Baseline

  5. Motivation for knee exercises

    Measured on a numeric rating scale from 0 to 10, with 10 indicating highly motivated for exercising.

    Time frame: Baseline

  6. Motivation for knee surgery

    Measured on a numeric rating scale from 0 to 10, with 10 indicating highly motivated for undergoing knee surgery

    Time frame: Baseline

  7. Self-reported exercise

    Measured with a question on how often the individual exercise with increased breathing and heart rate for at least 30 minutes. With five response categories (3 times or more per week; 1-2 times per week; 1-2 times per month; do not exercise regularily; cannot exercise)

    Time frame: Baseline, 2 months, 6 months, 12 months

  8. Global rating of change in the knee

    One question with five response categories asking about experience of change in the knee. Responses from "a very small degree" to "a very large degree"

    Time frame: 2 months, 6 months, 12 months

  9. Digital self-efficacy

    Six questions measuring how well the patients manage smartphones, padlets, pc, apps, and login with BankID and Helsenorge.no. Answered on a 5-point scale fron very poorly to very good, with an additional option of "never tried"

    Time frame: Baseline

  10. Demographics

    Questions about age, gender, hight, weight, education level, working status, living arrangements, smoking, comorbidities.

    Time frame: Baseline

  11. Joint-spesific measures

    Questions related to referred joint, other joints with pain/problems

    Time frame: Baseline

  12. Current treatment

    Questions about if and how often they have been visiting a physiotherapist (1 and 3 months only for the remote monitoring group)

    Time frame: Baseline, 1, 2, 3, 6 and 12 months

  13. Satisfaction with follow-up

    Measured on a five-point Likert scale, from "very satisfied" to "very dissatisfied"

    Time frame: 6 and 12 months

  14. Usability of remote follow-up

    Measured with two questions from the system usability scale, modified to this study. The questions focus on the ease of answering the questionnaires and if help was needed. Measured on a 5-point likert scale from "totally disagree" to "totally agree"

    Time frame: 6 and 12 months

  15. Adherence to answering remote monitoring questionnaire

    Number of remote monitoring questionnaires answered (1, 2, 3, 6 and 12 months)

    Time frame: 1, 2, 3, 6 and 12 months

  16. Previous treatment

    Reporting of previous treatment (physiotherapy, osteoarthritis seminars, previous surgery in referred knee, previous arthroplasty in opposite knee)

    Time frame: Baseline

  17. Socioeconomic status

    Reporting of sosioeconomic status and if they have someone to help if needed

    Time frame: Baseline

  18. Change in use of medication

    Self-reported change in medication use (1 and 3 months only for remote monitoring group)

    Time frame: 1, 2, 3 and 6 months

  19. Fear of movement

    Measured on a 7-point likert scale, measurement at 1 and 3 months only for the remote monitoring group. Response categories from "totally disagree" to "totally agree"

    Time frame: Baseline, 1, 2, 3 months

  20. Health competency

    Measured on a 5-point likert scale, related to the understanding of their osteoarthritis disease and the treatment of their disease. Response categories from "completely" to "not at all"

    Time frame: Baseline

  21. Expectations about treatment

    Measured with two questions from the Standford Expectations of Treatment Scale, focusing on expectations about the result of surgery. In addition, one question about expectancy of improvement with exercise. All measured on 7-point likert scales, from "totally disagree" to "totally agree".

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Due to GDPR regulations, IPD cannot be shared

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2025 (actual). Primary completion is estimated for May 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2025
First posted
Jun 4, 2025
StartActual
Jun 4, 2025
Primary completionEst.
May 15, 2027
CompletionEst.
Dec 31, 2035
Last update
May 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07003932
Lead sponsor
Diakonhjemmet Hospital
Responsible party
Anne Therese Tveter (Professor, Diakonhjemmet Hospital) — Principal investigator
First posted
Jun 4, 2025
Start date
Jun 4, 2025
Primary completion
May 15, 2027 (estimated)
Completion
Dec 31, 2035 (estimated)
Last update
May 19, 2026

Study contacts

Anne Therese Tveter, PhD
Contact
a.t.tveter@medisin.uio.no
+47 91115550

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion